Table 3.
Toxicity Grade |
|||||
---|---|---|---|---|---|
Toxicity term | 1 | 2 | 3 | 4 | 5 |
Nausea | 11 | 2 | |||
Vomiting | 8 | 2 | 1 | ||
Fatigue | 7 | 1 | |||
Headache | 4 | ||||
Anorexia | 3 | 1 | |||
Abdominal pain | 3 | ||||
Pruritus | 3 | ||||
Constipation | 2 | 1 | |||
Lymphopenia | 1 | 1 | 1 | ||
Ataxia | 1 | 1 | |||
Rash | 1 | 1 | |||
Extrapyramidal/involuntary movement | 2 | ||||
Hemiparesis | 2 | ||||
Neurology–motor (gait) | 1 | 1 | |||
Neutropenia | 1 (DLT) | ||||
Alopecia | 1 | ||||
Cushingoid appearance | 1 | ||||
Fever | 1 | ||||
Striae | 1 | ||||
Diarrhea | 1 | ||||
Infection | 1 | ||||
Tinnitus | 1 | ||||
Tachypnea | 1 | ||||
Insomnia | 1 | ||||
Hypertension | 1 | ||||
Mucositis | 1 | ||||
Prolonged QTc | 1 | ||||
Neuropathy–sensory | 1 | ||||
Hypokalemia | 1 | ||||
Hypomagnesemia | 1 | ||||
Cough | 1 | ||||
Allergic reaction | 1 | ||||
Leukopenia | 1 | ||||
Flushing | 1 | ||||
Cardiac–other (T-wave abnormality) | 1 |
aAccording to the Common Terminology Criteria for Adverse Events, version 3.0 for all findings with a possible, probably, or definite attribution to ATO administration in the 22 patients evaluable for toxicity.